CCM
DMRA

Connective Capital Management’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Connective Capital Management’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,956
Closed -$100K – 69
2025
Q3 		$100K Buy
+26,956
New +$91.3K 0.09% 65

Other funds holding DMRA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Connective Capital Management's DMRA Position: Q4 2025 in Review

Connective Capital Management sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q4 2025, closing a stake of 26,956 shares — an estimated $100K sold.

Connective Capital Management first reported a position in DMRA in Q3 2025 and held it in 1 quarter. The position peaked at $100K in Q3 2025. 18 funds tracked by Wall St. Rank hold DMRA as of Q4 2025.

  • Connective Capital Management reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q4 2025 after selling out during the quarter.
  • Connective Capital Management sold 26,956 Damora Therapeutics, Inc. Ordinary Shares shares in Q4 2025, an estimated $100K.
  • Connective Capital Management first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q3 2025 and held it in 1 quarter.
  • Connective Capital Management's Damora Therapeutics, Inc. Ordinary Shares position peaked at $100K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q4 2025.

Based on Connective Capital Management's 13F filing for Q4 2025, filed 19 Feb 2026.